Bisker-Leib Vered has filed 6 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 49198 shares of Compass Therapeutics, Inc. ($CMPX) on February 08, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 8, 2024 | Compass Therapeutics, Inc. | $CMPX | Bisker-Leib Vered | CHIEF EXECUTIVE OFFICER | F | Common Stock | 49198 | $1.45 | 3,124,426.0000 | 0 | 1.55% | 0.00% |
| Jan. 9, 2024 | Compass Therapeutics, Inc. | $CMPX | Bisker-Leib Vered | Chief Executive Officer | A | Common Stock | 1753125 | $1.93 | 3,173,624.0000 | 0 | 123.42% | 0.00% |
| Jan. 9, 2024 | Compass Therapeutics, Inc. | $CMPX | Bisker-Leib Vered | Chief Executive Officer | A | Stock Option (Right to Buy) | 1753125 | $0.00 | 1,753,125.0000 | 0 | 9999.99% | 0.00% |
| Nov. 17, 2023 | Compass Therapeutics, Inc. | $CMPX | Bisker-Leib Vered | Chief Operating Officer | F | Common Stock | 64415 | $1.50 | 1,420,499.0000 | 0 | 4.34% | 0.00% |
| Feb. 8, 2023 | Compass Therapeutics, Inc. | $CMPX | Bisker-Leib Vered | Chief Operating Officer | A | Common Stock | 400000 | $0.00 | 1,484,914.0000 | 0 | 36.87% | 0.00% |
| Feb. 8, 2023 | Compass Therapeutics, Inc. | $CMPX | Bisker-Leib Vered | Chief Operating Officer | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |